Type 2 Diabetes Market
                     Type 2 
Diabetes 
Market
( D i p e p ti d y l  P e p ti d a s e - 4  ( D P P - 4 )  I n h i b i t o r s ,  G l u c a g o n - L i k e  P e p ti d e - 1  ( G L P - 1 )  R e c e p t o r  
A g o n i s t s ,  T h i a z o l i d i n e d i o n e s ,  A l p h a - g l u c o s i d a s e  I n h i b i t o r s ,  S u l f o n y l u r e a s  O t h e r  I n s u l i n  
S e c r e t a g o g u e s ,  B i g u a n i d e s ,  S o d i u m G l u c o s e  C o t r a n s p o r t e r  2  I n h i b i t o r s )  a n d  b y  
A p p l i c a ti o n  ( G l y c e m i c  C o n t r o l ,  C a r d i o v a s c u l a r  S a f e t y ,  H y p o g l y c e m i a  A v o i d a n c e ,  O t h e r s ) :  
G l o b a l  O p p o r t u n i t y  A n a l y s i s  a n d  I n d u s t r y  F o r e c a s t ,  2 0 2 3 - 2 0 3 2
Prime determinants of growth  
Download Sample Copy of Report
Type 2 diabetes (T2D) is a chronic disease that affects bodys blood sugar 
level. Elevated blood sugar level (hyperglycemia) causes detrimental effects 
on heart, kidneys, eyes, blood vessels, and nerves.
The major factor that drive the growth of the global type 2 diabetes (T2D) 
market are increase in prevalence of T2D disease globally. As per NCBI, 89 
million cases of T2DM were recorded in 2014, and its prevalence is expected to 
reach to 330 million cases by 2022. Moreover, advancements in diabetic 
medications by pharmaceutical manufacturers fuel the market growth.
Recent developments in Type 2 
Diabetes Market
Personalized Medicine: The Type 2 Diabetes Market was increasingly ► Artificial Intelligence (AI): AI was being used to analyze patient data, 
focusing on personalized treatment approaches. This includes the use of detect trends, and provide more accurate and timely diabetes management 
genetic information and patient-specific data to tailor treatment plans and recommendations. AI was also aiding in drug discovery and development.
medications.
GlaxoSmithKline Plc.
Pfizer Inc.
Novo Nordisk
KEY Merck & Co., Inc.
AstraZeneca Plc. 
PLAYERS:
Bayer AG, Chugai Pharmaceutical Co.
Bristol-Myers Squibb
Sanofi Aventis A/S
Eli Lilly and Co.
BY REGION:
•North America (U.S.,
•Canada, Mexico)
•Europe (France, Germany, Italy,
•Spain, UK, Rest of Europe)
•Asia-Pacific (China, Japan, India, 
South Korea, Australia, Rest of Asia-
Pacific)
•LAMEA (Brazil, South Africa, Saudi 
Arabia, Rest of LAMEA)
CONTACT US:
•David Correa 
•5933 NE Win Sivers Drive 
•#205, Portland, OR 97220 
•United States 
•Toll-Free: 1-800-792-5285 
•UK: +44-845-528-1300 
•Hong Kong: +852-301-84916 
•India (Pune): +91-20-66346060 
•Fax: +1-855-550-5975 
•[email protected] 
•Web: https://www.alliedmarketresearch.com 
•Follow Us on: LinkedIn Twitter
THANK 
YOU !